Harry H Mansbach 89bio, Inc. (ETNB) insider trading activity

Harry H Mansbach is Chief Medical Officer of 89bio, Inc.. Currently has a direct ownership of 158,437 shares of ETNB, which is worth approximately $1.2 Million. The most recent transaction as insider was on Feb 17, 2024, when has been sold 1,046 shares (Common Stock) at a price of $9.74 per share, resulting in proceeds of $10,188. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 158K

0% 3M change

50.07% 12M change

Total Value Held $1.2 Million

Harry H Mansbach Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 17 2024	SELL Payment of exercise price or tax liability	$10,188 $9.74 p/Share	1,046 Reduced 0.66%	158,437 Common Stock
Feb 09 2024	SELL Payment of exercise price or tax liability	$30,149 $8.45 p/Share	3,568 Reduced 2.19%	159,483 Common Stock
Feb 05 2024	SELL Payment of exercise price or tax liability	$11,662 $9.8 p/Share	1,190 Reduced 0.72%	163,051 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	48,750 Added 22.89%	164,241 Common Stock
Jan 05 2024	SELL Payment of exercise price or tax liability	$111,506 $11.53 p/Share	9,671 Reduced 7.73%	115,491 Common Stock
Jan 05 2024	BUY Grant, award, or other acquisition	-	25,000 Added 16.65%	125,162 Common Stock
Sep 09 2023	SELL Payment of exercise price or tax liability	$63,466 $16.61 p/Share	3,821 Reduced 3.67%	100,162 Common Stock

Aug 17 2023	SELL Payment of exercise price or tax liability	$15,676 $15.46 p/Share	1,014 Reduced 0.97%	103,983 Common Stock
Aug 01 2023	SELL Payment of exercise price or tax liability	$9,024 $15.64 p/Share	577 Reduced 0.55%	104,997 Common Stock
Jun 30 2023	SELL Payment of exercise price or tax liability	$54,613 $18.95 p/Share	2,882 Reduced 2.66%	105,574 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	-	8,334 Added 7.14%	108,456 Common Stock
Mar 31 2023	SELL Payment of exercise price or tax liability	$43,892 $15.23 p/Share	2,882 Reduced 2.8%	100,122 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	-	8,333 Added 7.48%	103,004 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$29,714 $13.97 p/Share	2,127 Reduced 2.2%	94,671 Common Stock
Feb 09 2023	BUY Grant, award, or other acquisition	-	30,000 Added 23.66%	96,798 Common Stock
Feb 05 2023	SELL Payment of exercise price or tax liability	$18,006 $13.24 p/Share	1,360 Reduced 2.0%	66,798 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$8,194 $12.05 p/Share	680 Reduced 0.99%	68,158 Common Stock
Nov 15 2022	SELL Payment of exercise price or tax liability	$30,476 $9.79 p/Share	3,113 Reduced 4.33%	68,838 Common Stock
Nov 15 2022	BUY Grant, award, or other acquisition	-	9,000 Added 11.12%	71,951 Common Stock
Sep 28 2022	SELL Payment of exercise price or tax liability	$16,600 $5.76 p/Share	2,882 Reduced 4.38%	62,951 Common Stock
Sep 28 2022	BUY Grant, award, or other acquisition	-	8,333 Added 11.24%	65,833 Common Stock
Sep 09 2022	BUY Grant, award, or other acquisition	-	25,000 Added 30.3%	57,500 Common Stock
Feb 17 2022	BUY Grant, award, or other acquisition	-	22,500 Added 40.91%	32,500 Common Stock
Feb 05 2022	SELL Payment of exercise price or tax liability	$7,128 $5.23 p/Share	1,363 Reduced 4.19%	31,137 Common Stock
Feb 05 2021	BUY Grant, award, or other acquisition	-	10,000 Added 50.0%	10,000 Common Stock

HHM

Harry H Mansbach

Chief Medical Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ETNB shares.

Notify only if

Value

Insider Trading

Get notified when an 89bio, Inc. insider buys or sells ETNB shares.

Notify only if

Operation

Value

Type

News

Receive news related to 89bio, Inc.

Track Activities on ETNB

Account